FR2782270B1 - ADENOSINE AND ORAL ADENYL NUCLEOTIDES FOR IMPROVING MUSCLE WORK - Google Patents

ADENOSINE AND ORAL ADENYL NUCLEOTIDES FOR IMPROVING MUSCLE WORK

Info

Publication number
FR2782270B1
FR2782270B1 FR9810325A FR9810325A FR2782270B1 FR 2782270 B1 FR2782270 B1 FR 2782270B1 FR 9810325 A FR9810325 A FR 9810325A FR 9810325 A FR9810325 A FR 9810325A FR 2782270 B1 FR2782270 B1 FR 2782270B1
Authority
FR
France
Prior art keywords
adenosine
oral
improving muscle
muscle work
adenyl nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9810325A
Other languages
French (fr)
Other versions
FR2782270A1 (en
Inventor
Jean Angignard
Dilda Stephanie Decollogne
Ketty Kichenin
Michel Seman
Jean Gilles Vernin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9810325A priority Critical patent/FR2782270B1/en
Publication of FR2782270A1 publication Critical patent/FR2782270A1/en
Application granted granted Critical
Publication of FR2782270B1 publication Critical patent/FR2782270B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9810325A 1998-08-12 1998-08-12 ADENOSINE AND ORAL ADENYL NUCLEOTIDES FOR IMPROVING MUSCLE WORK Expired - Lifetime FR2782270B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9810325A FR2782270B1 (en) 1998-08-12 1998-08-12 ADENOSINE AND ORAL ADENYL NUCLEOTIDES FOR IMPROVING MUSCLE WORK

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9810325A FR2782270B1 (en) 1998-08-12 1998-08-12 ADENOSINE AND ORAL ADENYL NUCLEOTIDES FOR IMPROVING MUSCLE WORK

Publications (2)

Publication Number Publication Date
FR2782270A1 FR2782270A1 (en) 2000-02-18
FR2782270B1 true FR2782270B1 (en) 2001-06-22

Family

ID=9529613

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9810325A Expired - Lifetime FR2782270B1 (en) 1998-08-12 1998-08-12 ADENOSINE AND ORAL ADENYL NUCLEOTIDES FOR IMPROVING MUSCLE WORK

Country Status (1)

Country Link
FR (1) FR2782270B1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227371A (en) * 1982-07-13 1993-07-13 Eliezer Rapaport Utilization of adenine nucleotides and/or adenosine and inorganic phosphate for elevation of liver, blood and blood plasma adenosine 5'-triphosphate concentrations
DE3701497A1 (en) * 1987-01-20 1988-07-28 Frankhof Wolfgang MEDICINAL PRODUCTS CONTAINING LOCALANAESTHETIC AND NUCLEOSIDES AND THE USE THEREOF FOR TREATING MUSCLE INJURIES
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
IT1247125B (en) * 1991-03-01 1994-12-12 Depha Team Srl DIETETIC OR PHARMACEUTICAL COMPOSITIONS FOR THE RESTORATION OF THE CELL CONTENT OF NUCLEOTID ADENINS IN THE SKELETAL AND CARDIAC MUSCLE.
US5707971A (en) * 1995-06-07 1998-01-13 Life Resuscitation Technologies, Inc. Modulation of glycolytic ATP production
JP4526047B2 (en) * 1995-11-08 2010-08-18 雪印乳業株式会社 Strength enhancer

Also Published As

Publication number Publication date
FR2782270A1 (en) 2000-02-18

Similar Documents

Publication Publication Date Title
AP2005003213A0 (en) 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections.
DE69612977D1 (en) AMORPHE SILIC ACIDS AND ORAL COMPOSITIONS
NO975585D0 (en) C-4 'modified adenosine kinase inhibitors
ITBO970001A0 (en) DEVICE FOR PERFORMING BIOPSIES
GB2324943B (en) High speed interconnect bus
PL321046A1 (en) Method of obtaining 1-2'-deoxy-2',2'-difluoro-d-ribofuranosil)-4-amidopyrimidin-2-one hydrochloride
EE200000784A (en) Adenosine derivatives
DE69818798D1 (en) High-speed Montgomery value calculation
DK1129520T3 (en) Through Bus Termination Circuits
ATE263550T1 (en) ORAL CYCLOSPORINE FORMULATIONS
AU2002214477A1 (en) Modified nucleosides and nucleotides and use thereof
FR2760102B1 (en) ADJUSTABLE SELF-DIRECTING
FR2782270B1 (en) ADENOSINE AND ORAL ADENYL NUCLEOTIDES FOR IMPROVING MUSCLE WORK
DE69916425D1 (en) ANTIVIRAL AGENTS
DE69907161D1 (en) 5 'DEOXYCYTIDINE DERIVATIVES
AU3379199A (en) Arabinofuranosyl benzimidazoles as antiviral agents
AR025731A1 (en) "DITIEPINO [6,5-B] BENZO-FUSIONATED PYRIDINS AND RELATED COMPOSITIONS AND METHODS"
EP1446132A4 (en) Antidiabetic 2-substituted-5'-o- (1-boranotriphosphate) adenosine derivatives
ID30458A (en) OSANETAN IN TREATMENT OF SOUL DISORDERS
FR2783718B3 (en) FIXED TRAINING BICYCLE
ITBO20000740A0 (en) DRAFT TRANSFER METHOD AND UNIT
DE69528372D1 (en) ORAL TREATMENT
PL105075U1 (en) Convection-type central heting radiator in particulat for bathrooms
Stepula et al. Endorectal ultrasonic studies in evaluation of rectum cancer local spreading.; Endorektalne ultrazvukove doslyidzhennya pri otsyintsyi myistsevogo rozpovsyudzhennya raku pryamoyi kishki.
FR2736832B1 (en) INTERFERON-GAMMA POTENTIALIZING AGENT

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20